Sep 21, 2026 9 0
Uploaded by Theodore
Favorite
Share
More Options
5
Olaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: The OPHELIA phase 2 study_Page 1

Open in WPS to view all 5 pages